IsoRay, Inc. (ISR) on Display at the American Brachytherapy Society Convention Featuring Its Cesium-131 Cancer Fighting Portfolio
4/15/2013 9:30:09 AM
More...
|
First International Brain Cancer Treatments Performed Utilizing IsoRay, Inc. (ISR)'s GliaSite Radiation Therapy System
2/21/2013 8:49:42 AM
More...
|
IsoRay, Inc. (ISR) Reports Second Quarter Results
2/14/2013 9:02:14 AM
More...
|
IsoRay, Inc. (ISR)'s Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell Medical College and Barrow Neurological Institute to the Society of Neuro-Oncology
12/11/2012 9:39:05 AM
More...
|
IsoRay, Inc. (ISR)'s Brain and Lung Cancer Products Showcased at the American Society for Radiation Oncology (ASTRO) Convention
10/29/2012 10:47:18 AM
More...
|
IsoRay, Inc. (ISR) Reports Fiscal Year 2012 Results
9/28/2012 8:19:45 AM
More...
|
IsoRay, Inc. (ISR) Announces Financing of $3.5 Million to Advance Its GliaSite and New Emerging Cancer Solutions for Internal Radiation Therapy
7/16/2012 8:07:20 AM
More...
|
IsoRay, Inc. (ISR) Announces First International Orders for GliaSite Radiation Therapy System
7/11/2012 8:49:23 AM
More...
|
IsoRay, Inc. (ISR) Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
6/5/2012 9:04:54 AM
More...
|
IsoRay, Inc. (ISR)'s Cesium-131 Prostate Cancer Treatment Featured on Discovery Channel
5/29/2012 9:00:54 AM
More...
|
|